377 related articles for article (PubMed ID: 17458439)
21. Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?
Lunn ML; Santos CB; Craig TJ
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):211-4. PubMed ID: 20377110
[TBL] [Abstract][Full Text] [Related]
22. Management of dental-oral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency.
Jurado-Palomo J; Muñoz-Caro JM; López-Serrano MC; Prior N; Cabañas R; Pedrosa M; Burgueño M; Caballero T
J Investig Allergol Clin Immunol; 2013; 23(1):1-6. PubMed ID: 23653967
[TBL] [Abstract][Full Text] [Related]
23. Acute upper airway obstruction from acquired angioedema.
Cheng WY; Smith WB; Russell WJ
Emerg Med Australas; 2007 Feb; 19(1):65-7. PubMed ID: 17305664
[TBL] [Abstract][Full Text] [Related]
24. Nonallergic angioedema: role of bradykinin.
Bas M; Adams V; Suvorava T; Niehues T; Hoffmann TK; Kojda G
Allergy; 2007 Aug; 62(8):842-56. PubMed ID: 17620062
[TBL] [Abstract][Full Text] [Related]
25. Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema.
Kelemen Z; Moldovan D; Mihály E; Visy B; Széplaki G; Csuka D; Füst G; Farkas H; Varga L
Clin Immunol; 2010 Mar; 134(3):354-8. PubMed ID: 19945350
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
Castelli R; Zanichelli A; Cugno M
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
[TBL] [Abstract][Full Text] [Related]
27. Pathophysiology of hereditary angioedema.
Zuraw BL; Christiansen SC
Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
[TBL] [Abstract][Full Text] [Related]
28. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor.
Sigler C; Annis K; Cooper K; Haber H; Van deCarr S
Arch Dermatol; 1997 Aug; 133(8):972-5. PubMed ID: 9267242
[TBL] [Abstract][Full Text] [Related]
29. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus.
Cacoub P; Frémeaux-Bacchi V; De Lacroix I; Guillien F; Kahn MF; Kazatchkine MD; Godeau P; Piette JC
Arthritis Rheum; 2001 Aug; 44(8):1836-40. PubMed ID: 11508436
[TBL] [Abstract][Full Text] [Related]
30. [Hereditary angioedema: changes in serum levels of C4 in response to danazol].
Egidio Fabiani J; Squiquera L; Leoni J; Simkin G; Casala A
Med Cutan Ibero Lat Am; 1987; 15(6):461-7. PubMed ID: 3323703
[TBL] [Abstract][Full Text] [Related]
31. The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.
Csuka D; Munthe-Fog L; Skjoedt MO; Kocsis A; Zotter Z; Gál P; Varga L; Farkas H; Füst G; Garred P
Mol Immunol; 2013 Jul; 54(3-4):271-7. PubMed ID: 23318225
[TBL] [Abstract][Full Text] [Related]
32. Effect of C1-Esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema.
Greve J; Bas M; Hoffmann TK; Schuler PJ; Weller P; Kojda G; Strassen U
Laryngoscope; 2015 Jun; 125(6):E198-202. PubMed ID: 25583256
[TBL] [Abstract][Full Text] [Related]
33. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Joseph K; Tholanikunnel TE; Kaplan AP
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
[TBL] [Abstract][Full Text] [Related]
34. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
[TBL] [Abstract][Full Text] [Related]
35. Acquired angioedema associated with primary antiphospholipid syndrome in a patient with antithrombin III deficiency.
Széplaki G; Varga L; Szépvölgyi A; Simon K; Blaskó B; Nagy E; Karádi I; Füst G; Farkas H
Int Arch Allergy Immunol; 2008; 146(2):164-8. PubMed ID: 18204284
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
[TBL] [Abstract][Full Text] [Related]
37. [Hereditary angioedema. Effect of danazol on C4 and functional C1INH].
Fabiani JE; Paulin P; Simkin G; Leoni J; Palombarani S; Squiquera L
Rev Alerg Mex (1987); 1989; 36(3):99-104. PubMed ID: 2772500
[TBL] [Abstract][Full Text] [Related]
38. Hereditary angioedema: case report of a family.
Yilmaz M; Kendirli SG; Altintaş D; Bingöl G
Turk J Pediatr; 2000; 42(3):230-3. PubMed ID: 11105624
[TBL] [Abstract][Full Text] [Related]
39. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency.
Bork K; Hardt J; Witzke G
J Allergy Clin Immunol; 2012 Sep; 130(3):692-7. PubMed ID: 22841766
[TBL] [Abstract][Full Text] [Related]
40. [Hereditary or acquired angioedema caused by functional deficiency of C1 inhibitor--a still unfamiliar disease picture].
Wüthrich B; Devay J; Späth P
Schweiz Med Wochenschr; 1999 Feb; 129(7):285-91. PubMed ID: 10093876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
